Gastrointestinal absorption of recombinant human insulin-like growth factor-I in rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 283, Issue 2, 1997, Pages 611-618

  Kimura, Toshikiro ^a   Murakawa, Yusuke ^a   Ohno, Misako ^a   Ohtani, Seiji ^a   Higaki, Kazutaka ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; CASEIN; RECOMBINANT SOMATOMEDIN C; TRICHLOROACETIC ACID;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL FRACTIONATION; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DEGRADATION; ENDOCYTOSIS; IMMUNOTHERAPY; INTESTINE ABSORPTION; INTESTINE MUCOSA; MALE; MOLECULAR WEIGHT; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; SMALL INTESTINE;

ANIMALS; BIOLOGICAL AVAILABILITY; BIOLOGICAL TRANSPORT; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTESTINAL ABSORPTION; MALE; MOLECULAR WEIGHT; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS;

EID: 0030815879     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. ASADA, H., DOUEN, T., MIZUKOSHI, Y., FUJITA, T., MURAKAMI, M., YAMAMOTO, A. AND MURANISHI, S.: Stability of acyl derivatives of insulin in the small intestine: Relative importance of insulin association characteristics in aqueous solution. Pharm. Res. 11: 1115-1120, 1994.
2. BAI, J. P. F.: Colonic delivery of peptide and protein drugs: Consideration of intracellular proteolytic enzymes. S.T.P. Pharma Sci. 5: 30-35, 1995.
3. BAI, J. P. F. AND CHANG, L. L.: Transepithelial transport of insulin. I. Insulin degradation by insulin-degrading enzyme in small intestinal epithelium. Pharm. Res. 12: 1171-1175, 1995.
4. DEMEYTS, P.: The structural basis of insulin and insulin-like growth factor-I receptor binding and negative cooperativity, and its relevance to mitogenic versus metabolic signalling. Diabetologia 37: S135-S148, 1994.
5. GOTOH, S., NAKAMURA, R., NISHIYAMA, M., FUJITA, T., YAMAMOTO, A. AND MURANISHI, S.: Does bacitracin have an absorption-enhancing effect in the intestine? Biol. Pharm. Bull. 18: 794-796, 1995.
6. HIRAI, S., YASHIKI, T. AND MIMA, H.: Effect of surfactants on the nasal absorption of insulin in rats. Int. J. Pharm. 9: 165-172, 1981.
7. HUMBEL, R. E.: Insulin-like growth factors I and II. Eur. J. Biochem. 190: 445-462, 1990.
8. KAKEMI, K., SEZAKI, H., KONISHI, R., KIMURA, T. AND OKITA, A.: Effect of bile salts on the gastrointestinal absorption of drugs. II. Mechanism of the enhancement of the intestinal absorption of sulfaguanidine by bile salts. Chem. Pharm. Bull. 18: 1034-1039, 1970.
9. KIMURA, T., KANZAKI, Y., MATSUMOTO, Y., MANDAI, M., KUROSAKI, Y. AND NAKAYAMA, T.: Disposition of recombinant human insulin-like growth factor-I in normal and hypophysectomized rats. Biol. Pharm. Bull. 17: 310-315, 1994.
10. LEE, V. H. L.: Protease inhibitors and penetration enhancers as approaches to modify peptide absorption. J. Controlled Rel. 13: 213-223, 1990.
11. LOWRY, O. H., ROSENBROUGH, N. J., FARR, A. L. AND RANDALL, R. J.: Protein measurement with the Folin phenol reagents. J. Biol. Chem. 193: 265-275, 1951.
12. PHILLIPS, A. F., RAO, R., ANDERSON, G. G., MCCRACKEN, D. M., LAKE, M. AND KOLDOVSKY, O.: Fate of insulin-like growth factors I and II administered orogastrically to suckling rats. Pediat. Res. 37: 586-592, 1995.
13. PORTER, P. R., SANGER, F. AND WETTS, D. C.: Structure and function of protein and nucleic acid. Biochem. Soc. Trans. 11: 411-425, 1983.
14. RAO, R. K., KOLDOVSKY, O. AND DAVIS, T. P.: Inhibition of intestinal degradation of somatostatin by rat milk. Am. J. Physiol. 258: G426-G431, 1990.
15. RAO, R. K., LAM, K., PHILLIPS, A. F., WILLIAMS, C., LAKE, M. AND KOLDOVSKY, O.: Presence of multiple forms of peptidase inhibitors in rat milk. J. Pediatr. Gastroenterol. Nutr. 17: 414-420, 1993.
16. SUZUKI, K., HASHIMOTO, K., ASADA, T., NAKANISHI, S., HORIAI, H. AND NIWA, M.: Measurement of IGF-I/somatomedin-C in plasma by radioimmunoassay (RIA). Study on RIA using antiserum and monoclonal antibody against recombinant IGF-I. Clin. Pharmacol. (Jpn) 35: 853-858, 1987.
17. TERASAKI, T., HIRAI, K.-I., SATO, H., KANG, Y. S. AND TSUJI, A.: Absorptive-mediated endocytosis of a dynorphin-like analgesic peptide, E-2078, into the blood-brain barrier. J. Pharmacol. Exp. Ther. 251: 351-357, 1989.
18. UKAI, K., MURAKAWA, Y., KUROSAKI, Y., NAKAYAMA, T. AND KIMURA, T.: Nasal absorption of recombinant human insulin-like growth factor-I. Yakuzaigaku 56: 156-162, 1996.
19. VACHER, P.-Y., BESTETTI, G. AND BLUM, J. W.: Insulin-like growth factor I absorption in the jejunum of neonatal calves. Biol. Neonate 68: 354-367, 1995.
20. YAMAMOTO, A., TANIGUCHI, T., RIKYUU, K., TSUJI, T., FUJITA, T., MURAKAMI, M. AND MURANISHI, S.: Effect of various protease inhibitors on the intestinal absorption and degradation of insulin in rats. Pharm. Res. 11: 1496-1500, 1994.
21. YAMAOKA, K., NAKAGAWA, T. AND UNO, T.: Statistical moments in pharmacokinetics. J. Pharmacokinet. Biopharm. 6: 547-558, 1978.
22. XIAN, C. J., SHOUBRIDGE, C. A. AND READ, L. C.: Degradation of IGF-I in the adult rat gastrointestinal tract is limited by a specific antiserum or the dietary protein casein. J. Endocrinol. 146: 215-225, 1995.
23. Xu, R.-J.: Development of the newborn GI tract and its relation to colostrum/ milk intake: A review. Reprod. Fertil. Dev. 8: 35-48, 1996.
24. Xu, R.-J. AND WANG, T.: Gastrointestinal absorption of insulinlike growth factor-I in neonatal pigs. J. Pediat. Gastroenterol. Nutr. 23:430-437, 1996.